Akero Therapeutics Inc buy Morgan Stanley
Start price
28.01.25
/
50%
€49.44
Target price
28.01.26
€92.02
Performance (%)
-5.00%
Price
08.12.25
€46.97
Summary
This prediction is currently active. With a performance of -5.00%, the BUY prediction for Akero Therapeutics Inc by Morgan_Stanley is down slightly. This prediction currently runs until 28.01.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akero Therapeutics Inc | 0.278% | 0.278% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Morgan_Stanley for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Morgan Stanley from $46.00 to $96.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€38.28
10.03.25
10.03.25
-
10.03.26
10.03.26
22.70%
08.12.25
08.12.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€14.00
11.10.23
11.10.23
€31.05
11.10.24
11.10.24
92.86%
12.10.24
12.10.24